Blood transfusion (red cell or whole blood) · women with complete placenta praevia and intractable bleeding following caesarean section
It is very uncertain whether bakri balloon tamponade changes blood transfusion (red cell or whole blood) compared with haemostatic square suturing to the lower segment of the uterus… (very low certainty).
1 finding from 1 review
Blood transfusion (red cell or whole blood) · Women (aged between 20 and 40) diagnosed with primary PPH following 'normal' vaginal birth and unresponsive to medical treatment (Ashraf…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion (red cell or whole blood) · women with uncontrolled atonic PPH following caesarean section, and not responding to standard care (uterine massage, ecbolics and…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause · patients requiring blood transfusion (children with malaria and adults with a traumatic injury)
It is very uncertain whether long‐stored ('older') PRBC (≥ 21 days of storage) changes death from any cause compared with short‐stored (fresh) PRBC (< 21 days of storage) (very low certainty).
1 finding from 1 review
Adverse event (Metabolic acidosis) · patients requiring blood transfusion (children with malaria and adults with a traumatic injury)
1 finding from 1 review
Number of participants receiving a red cell transfusion (total) · participants undergoing surgery
It is very uncertain whether DDAVP changes number of participants receiving a red cell transfusion (total) compared with tranexamic acid (very low certainty).
1 finding from 1 review
Number of participants receiving a red cell transfusion (total) · participants undergoing surgery
DDAVP showed no clear difference in number of participants receiving a red cell transfusion (total) compared with placebo or standard care (moderate certainty).
1 finding from 1 review
Number of participants receiving a red cell transfusion (total) · participants undergoing surgery
DDAVP may leads to higher number of participants receiving a red cell transfusion (total) compared with aprotinin (low certainty).
1 finding from 1 review
Number of participants receiving a red cell transfusion (total) · participants with platelet dysfunction undergoing surgery
DDAVP showed no clear difference in number of participants receiving a red cell transfusion (total) compared with placebo or standard care: platelet dysfunction subgroup (low certainty).
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Low CVP versus control. · patients with liver resection.
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Haemodilution versus control. · patients with liver resection.
1 finding from 1 review
Mortality: in‐hospital mortality (within 24 hours) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (within 24 hours) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 7 days) · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: in‐hospital mortality (within 7 days) compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: time‐point not defined · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: time‐point not defined compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: short term (up to 30 days) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: short term (up to 30 days) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (time points varied) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (time points varied) compared with standard practice storage duration (moderate certainty).
1 finding from 1 review
ICU mortality · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐ICU mortality compared with standard practice storage duration (moderate certainty).
1 finding from 1 review
Mortality: short‐term mortality (up to 30 days) ‐ neonates · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: short‐term mortality (up to 30 days) ‐ neonates compared with standard practice storage duration (very low certainty).
1 finding from 1 review
Mortality: short‐term mortality (up to 30 days) ‐ adults · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: short‐term mortality (up to 30 days) ‐ adults compared with standard practice storage duration (moderate certainty).
1 finding from 1 review
Red cell volume transfused (total) · participants undergoing surgery
1 finding from 1 review